OpenEvidence, the ChatGPT for doctors, raises $200M at $6B valuation  

OpenEvidenceA tool that doctors and nurses compare to ChatGPT for medicine, plans to announce a $200 million raise at a $6 billion valuation, The New York Times reported.

The new funding comes three months after the startup raised a $210 million round at a $3.5 billion valuation, a testament to strong investor interest in industry-specific AI applications.

Trained in medical journals such as JAMA and the New England Journal of Medicine, the OpenEvidence platform helps users quickly find answers to existing medical knowledge to treat patients. Verified medical professionals can access OpenEvidence’s tool for free, which is supported by advertising.

OpenEvidence has grown rapidly since its founding in 2022. Its number of clinical consultations has nearly doubled to 15 million per month since July, according to The Times.

The round was led by Google Ventures, with participation from Sequoia Capital, Kleiner Perkins, Blackstone, Thrive Capital, Kotu Management, Bond and Kraft.

TechCrunch has reached out to OpenEvidence for comment.